These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 25572573)

  • 21. Long noncoding RNA MALAT1 releases epigenetic silencing of HIV-1 replication by displacing the polycomb repressive complex 2 from binding to the LTR promoter.
    Qu D; Sun WW; Li L; Ma L; Sun L; Jin X; Li T; Hou W; Wang JH
    Nucleic Acids Res; 2019 Apr; 47(6):3013-3027. PubMed ID: 30788509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FKBP3 Induces Human Immunodeficiency Virus Type 1 Latency by Recruiting Histone Deacetylase 1/2 to the Viral Long Terminal Repeat.
    Yang X; Zhao X; Zhu Y; Shen Y; Wang Y; Lu P; Jiang Z; Pan H; Yang J; Xun J; Zhao L; Wang J; Liang Z; Shen X; Liang Y; Lin Q; Liang H; Jin L; Zhang D; Liu J; Wang B; Jiang S; Xu J; Wu H; Lu H; Zhu H
    mBio; 2021 Aug; 12(4):e0079521. PubMed ID: 34281390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Latency: the hidden HIV-1 challenge.
    Marcello A
    Retrovirology; 2006 Jan; 3():7. PubMed ID: 16412247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic regulation of HIV-1 latency by cytosine methylation.
    Kauder SE; Bosque A; Lindqvist A; Planelles V; Verdin E
    PLoS Pathog; 2009 Jun; 5(6):e1000495. PubMed ID: 19557157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of HIV-1 latency by chromatin structure and nuclear architecture.
    Lusic M; Giacca M
    J Mol Biol; 2015 Feb; 427(3):688-94. PubMed ID: 25073101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic regulation of HIV-1 latency: focus on polycomb group (PcG) proteins.
    Khan S; Iqbal M; Tariq M; Baig SM; Abbas W
    Clin Epigenetics; 2018; 10():14. PubMed ID: 29441145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of histone methyltransferase GLP in HIV-1 latency through catalysis of H3K9 dimethylation.
    Ding D; Qu X; Li L; Zhou X; Liu S; Lin S; Wang P; Liu S; Kong C; Wang X; Liu L; Zhu H
    Virology; 2013 Jun; 440(2):182-9. PubMed ID: 23541084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors controlling chromatin organization and nucleosome positioning for establishment and maintenance of HIV latency.
    Sadowski I; Lourenco P; Malcolm T
    Curr HIV Res; 2008 Jun; 6(4):286-95. PubMed ID: 18691027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV-1 latency and eradication of long-term viral reservoirs.
    Coiras M; Lopez-Huertas MR; Alcami J
    Discov Med; 2010 Mar; 9(46):185-91. PubMed ID: 20350483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An upstream YY1 binding site on the HIV-1 LTR contributes to latent infection.
    Bernhard W; Barreto K; Raithatha S; Sadowski I
    PLoS One; 2013; 8(10):e77052. PubMed ID: 24116200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV Latency and the noncoding RNA therapeutic landscape.
    Saayman S; Roberts TC; Morris KV; Weinberg MS
    Adv Exp Med Biol; 2015; 848():169-89. PubMed ID: 25757621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment and molecular mechanisms of HIV-1 latency in T cells.
    van der Sluis RM; Jeeninga RE; Berkhout B
    Curr Opin Virol; 2013 Dec; 3(6):700-6. PubMed ID: 23953324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV Latency Gets a New Histone Mark.
    Nikolai BC; Feng Q
    Cell Host Microbe; 2017 May; 21(5):549-550. PubMed ID: 28494231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chromatin regulator PRC2 is a key regulator of epigenetic plasticity in glioblastoma.
    Natsume A; Ito M; Katsushima K; Ohka F; Hatanaka A; Shinjo K; Sato S; Takahashi S; Ishikawa Y; Takeuchi I; Shimogawa H; Uesugi M; Okano H; Kim SU; Wakabayashi T; Issa JP; Sekido Y; Kondo Y
    Cancer Res; 2013 Jul; 73(14):4559-70. PubMed ID: 23720055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of two candidate genes, NCoA3 and IRF8, potentially involved in the control of HIV-1 latency.
    Munier S; Delcroix-Genête D; Carthagéna L; Gumez A; Hazan U
    Retrovirology; 2005 Nov; 2():73. PubMed ID: 16305739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV-1 reactivation induced by apicidin involves histone modification in latently infected cells.
    Lin S; Zhang Y; Ying H; Zhu H
    Curr HIV Res; 2011 Jun; 9(4):202-8. PubMed ID: 21631428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Convergent evolution of chromatin modification by structurally distinct enzymes: comparative enzymology of histone H3 Lys²⁷ methylation by human polycomb repressive complex 2 and vSET.
    Swalm BM; Hallenbeck KK; Majer CR; Jin L; Scott MP; Moyer MP; Copeland RA; Wigle TJ
    Biochem J; 2013 Jul; 453(2):241-7. PubMed ID: 23679895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel histone deacetylase inhibitor NCH-51 activates latent HIV-1 gene expression.
    Victoriano AF; Imai K; Togami H; Ueno T; Asamitsu K; Suzuki T; Miyata N; Ochiai K; Okamoto T
    FEBS Lett; 2011 Apr; 585(7):1103-11. PubMed ID: 21402072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of novel genes associated with HIV-1 latency by analysis of histone modifications.
    Kim KC; Lee S; Son J; Shin Y; Yoon CH; Kang C; Choi BS
    Hum Genomics; 2017 May; 11(1):9. PubMed ID: 28499422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gradual shutdown of virus production resulting in latency is the norm during the chronic phase of human immunodeficiency virus replication and differential rates and mechanisms of shutdown are determined by viral sequences.
    Li XD; Moore B; Cloyd MW
    Virology; 1996 Nov; 225(1):196-212. PubMed ID: 8918547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.